W. Doepfner

2.2k total citations · 1 hit paper
24 papers, 1.7k citations indexed

About

W. Doepfner is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Organic Chemistry. According to data from OpenAlex, W. Doepfner has authored 24 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Molecular Biology and 3 papers in Organic Chemistry. Recurrent topics in W. Doepfner's work include Growth Hormone and Insulin-like Growth Factors (5 papers), Pituitary Gland Disorders and Treatments (3 papers) and Plant and fungal interactions (3 papers). W. Doepfner is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (5 papers), Pituitary Gland Disorders and Treatments (3 papers) and Plant and fungal interactions (3 papers). W. Doepfner collaborates with scholars based in Japan, United Kingdom and New Zealand. W. Doepfner's co-authors include U. Briner, Peter Marbach, Trevor J. Petcher, W. Bauer, R Huguenin, Janos Pless, A Cerletti, B. Berde, E. Flückiger and Jacky Vonderscher and has published in prestigious journals such as Endocrinology, Journal of Pharmacology and Experimental Therapeutics and Magnetic Resonance in Medicine.

In The Last Decade

W. Doepfner

24 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action

1982 1.1k citations W. Bauer, U. Briner et al. Life Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. Doepfner Japan	14	667	496	442	337	256	24	1.7k
K Raynor United States	20	564 0.8×	1.9k 3.8×	230 0.5×	166 0.5×	1.6k 6.4×	31	2.6k
Martha H. Corjay United States	18	159 0.2×	1.1k 2.2×	144 0.3×	280 0.8×	732 2.9×	24	2.0k
Yoshihiro Natori Japan	28	481 0.7×	251 0.5×	82 0.2×	109 0.3×	362 1.4×	100	2.1k
Hitoshi Noguchi Japan	20	367 0.6×	373 0.8×	303 0.7×	124 0.4×	65 0.3×	52	1.5k
Alessandro Bisello United States	32	227 0.3×	2.0k 4.1×	328 0.7×	745 2.2×	529 2.1×	65	2.8k
Sandra Siehler Switzerland	20	298 0.4×	833 1.7×	170 0.4×	93 0.3×	306 1.2×	29	1.2k
W.C. MacKellar United States	14	405 0.6×	616 1.2×	73 0.2×	349 1.0×	210 0.8×	19	2.4k
Ruth Navon Israel	29	362 0.5×	1.1k 2.3×	46 0.1×	132 0.4×	390 1.5×	80	2.5k
N. G. G. M. Abeling Netherlands	25	168 0.3×	943 1.9×	82 0.2×	224 0.7×	141 0.6×	84	2.0k
K. Ohno Japan	20	228 0.3×	458 0.9×	48 0.1×	247 0.7×	455 1.8×	48	1.8k

Countries citing papers authored by W. Doepfner

Since Specialization

Citations

This map shows the geographic impact of W. Doepfner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Doepfner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Doepfner more than expected).

Fields of papers citing papers by W. Doepfner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Doepfner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Doepfner. The network helps show where W. Doepfner may publish in the future.

Co-authorship network of co-authors of W. Doepfner

This figure shows the co-authorship network connecting the top 25 collaborators of W. Doepfner. A scholar is included among the top collaborators of W. Doepfner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Doepfner. W. Doepfner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rudin, Markus, U. Briner, & W. Doepfner. (1988). Quantitative magnetic resonance imaging of estradiol‐induced pituitary hyperplasia in rats. Magnetic Resonance in Medicine. 7(3). 285–291. 28 indexed citations

Sochor, Milena, et al.. (1988). The effect of a somatostatin analogue (SMS 201-995, sandostatin) on the concentration of phosphoribosyl pyrophosphate and the activity of the pentose phosphate pathway in the early renal hypertrophy of experimental diabetes in the rat. Biochemical Medicine and Metabolic Biology. 39(2). 226–233. 19 indexed citations

Doepfner, W., U. Briner, Peter Marbach, & Markus Rudin. (1986). Regression of oestrogen-induced pituitary hyperplasia after chronic treatment with sandostatin (SMS 201–995) in the rat. European Journal of Cancer and Clinical Oncology. 22(6). 749–749. 1 indexed citations

Plessis, Jeanetta du, W. Bauer, U. Briner, et al.. (1986). Chemistry and Pharmacology of SMS 201-995, a Long-Acting Octapeptide Analogue of Somatostatin. Scandinavian Journal of Gastroenterology. 21(sup119). 54–64. 126 indexed citations

Bauer, W., U. Briner, W. Doepfner, et al.. (1982). SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sciences. 31(11). 1133–1140. 1060 indexed citations breakdown →

Flückiger, E., U. Briner, Hans R. Bürki, et al.. (1979). Two novel prolactin release-inhibiting 8α-amino-ergolines. Cellular and Molecular Life Sciences. 35(12). 1677–1678. 25 indexed citations

Flückiger, E., U. Briner, W. Doepfner, et al.. (1978). Prolactin secretion inhibition by a new 8a-amino-ergoline, CH 29-717. Cellular and Molecular Life Sciences. 34(10). 1330–1332. 11 indexed citations

Doepfner, W. & U. Briner. (1977). Inhibition of gastric secretion and ulcer formation with synthetic salmon calcitonin in animal experiments.. PubMed. 16(2). 105–13. 1 indexed citations

Doepfner, W., et al.. (1976). Effects of synthetic salmon calcitonin on gastric secretion and ulcer formation in conscious cats and rats.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 60–70. 3 indexed citations

10.

Flückiger, E., et al.. (1976). Effects of ergot alkaloids on the hypothalamic-pituitary axis.. PubMed. 52suppl 1. 57–63. 41 indexed citations

11.

Ruch, W., A.L. Jaton, B. Bucher, Peter Marbach, & W. Doepfner. (1976). Alpha adrenergic control of growth hormone in adult male rats. Cellular and Molecular Life Sciences. 32(4). 529–531. 24 indexed citations

12.

Rosenthaler, J., et al.. (1968). Isolierung, Aminosäurezusammensetzung und tryptischer Abbau von Thyrocalcitonin aus Schweineschilddrüsen. Helvetica Chimica Acta. 51(1). 218–220. 7 indexed citations

13.

Doepfner, W., E. Stürmer, & B. Berde. (1963). On the Corticotrophin-Releasing Activity of Synthetic Neurohypophysial Hormones and Some Related Peptides. Endocrinology. 72(6). 897–902. 26 indexed citations

14.

Doepfner, W.. (1962). Biochemical observations on LSD-25 and deseril. Cellular and Molecular Life Sciences. 18(6). 256–257. 29 indexed citations

15.

Doepfner, W., et al.. (1961). Behavioral effects and brain amine content in rats.. PubMed. 134. 89–99. 66 indexed citations

16.

Doepfner, W., et al.. (1960). [Pharmacological characterization of deseril, a serotonin antagonist].. PubMed. 90. 1040–6. 51 indexed citations

17.

Cerletti, A & W. Doepfner. (1958). COMPARATIVE STUDY ON THE SEROTONIN ANTAGONISM OF AMIDE DERIVATIVES OF LYSERGIC ACID AND OF ERGOT ALKALOIDS. Journal of Pharmacology and Experimental Therapeutics. 122(1). 124–136. 52 indexed citations

18.

Doepfner, W. & A Cerletti. (1958). Über die Entstehung von Serotonin aus 5-Hydroxytryptophan nach UV.-Bestrahlung. Cellular and Molecular Life Sciences. 14(10). 376–377. 1 indexed citations

19.

Doepfner, W. & A Cerletti. (1958). Comparison of Lysergic Acid Derivatives and Antihistamines as Inhibitors of the Edema Provoked in the Rat’s Paw by Serotonin. International Archives of Allergy and Immunology. 12(1-2). 89–97. 64 indexed citations

20.

Doepfner, W. & A Cerletti. (1957). Über den Serotonin-Antagonismus einiger Antihistaminika unter Berücksichtigung ihrer chemischen Struktur. International Archives of Allergy and Immunology. 10(6). 348–354. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact